Congratulations to Fumiya Inaba (Integrative Oncology), for receiving a Canada Graduate Scholarships - Master's Award…
karnottMay 29, 2024
Dr. Cheryl Peters, a senior scientist in cancer prevention at BC Cancer and the BC…
karnottMay 28, 2024
Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design…
karnottMay 27, 2024
UBC Medicine researchers Drs. Robert Olson and Bernie Eigl have been honoured by Clinical Trials…
karnottMay 27, 2024
adMare BioInnovations (adMare) is pleased to announce the acceptance of five therapeutics start-ups from across…
karnottMay 24, 2024
Dr. Sally Otto—a theoretical biologist focused on fundamental questions of population genetics and evolution—has been…
karnottMay 24, 2024
High-grade serous ovarian cancer (HGSC) is a challenging disease, especially for patients with immunologically “cold”…
karnottMay 23, 2024
Nearly two years into the global pandemic, there remain a handful of approved therapies to…
pthomsonNovember 8, 2021
Michael Smith Health Research BC’s Scholar and Research Trainee awards provide funding to support BC’s…
pthomsonNovember 5, 2021
AbCellera (Nasdaq: ABCL) today announced an additional purchase by the U.S. government from Eli Lilly and…
pthomsonNovember 5, 2021
Over the last 10 years, SFU has invested in core facilities, which are purpose-built to…
pthomsonNovember 4, 2021
Researchers at UBC’s faculty of medicine and BC Cancer, in partnership with BC Children’s Hospital…
pthomsonNovember 3, 2021
In 2019, a novel, highly contagious coronavirus that caused respiratory illness began to spread globally,…
pthomsonNovember 2, 2021
Twice a year entrepreneurship@UBC recruits a cohort of research-based venture teams ready to translate their…
pthomsonNovember 2, 2021
NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech…
pthomsonNovember 1, 2021
